DC
FPRX

Deere & Company’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Deere & Company’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,319
Closed -$261K – 1124
2016
Q2 		$261K Buy
+6,319
New +$275K 0.01% 893
2015
Q1 		– Sell
-19,354
Closed -$523K – 1092
2014
Q4 		$523K Buy
+19,354
New +$333K 0.03% 588

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deere & Company's FPRX Position: Q3 2016 in Review

Deere & Company sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2016, closing a stake of 6,319 shares — an estimated $261K sold.

Deere & Company first reported a position in FPRX in Q4 2014 and held it in 2 quarters. The position peaked at $523K in Q4 2014. 176 funds tracked by Wall St. Rank hold FPRX as of Q3 2016.

  • Deere & Company reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 6,319 Five Prime Therapeutics, Inc. shares in Q3 2016, an estimated $261K.
  • Deere & Company first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 2 quarters.
  • Deere & Company's Five Prime Therapeutics, Inc. position peaked at $523K in Q4 2014.
  • 176 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.